{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:19:20Z","timestamp":1793949560642,"version":"4.8.0"},"reference-count":124,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T00:00:00Z","timestamp":1605657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>Neurological disorders, including Parkinson\u2019s disease (PD), have increased in prevalence and are expected to further increase in the coming decades. In this regard, PD affects around 3% of the population by age 65 and up to 5% of people over the age of 85. PD is a widely described, physically and mentally disabling neurodegenerative disorder. One symptom often poorly recognized and under-treated by health care providers despite being reported as the most common non-motor symptom is the finding of chronic pain. Compared to the general population of similar age, PD patients suffer from a significantly higher level and prevalence of pain. The most common form of pain reported by Parkinson\u2019s patients is of musculoskeletal origin. One of the most used combination drugs for PD is Levodopa-Carbidopa, a dopamine precursor that is converted to dopamine by the action of a naturally occurring enzyme called DOPA decarboxylase. Pramipexole, a D2 dopamine agonist, and apomorphine, a dopamine agonist, and Rotigotine, a dopamine receptor agonist, have showed efficacy on PD-associated pain. Other treatments that have shown efficacy in treating pain of diverse etiologies are acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), and cyclooxygenase-2 (COX-2) inhibitors. Opioids and opioid-like medications such as oxycodone, morphine, tramadol, and codeine are also commonly employed in treatment of chronic pain in PD. Other opioid related medications such as Tapentadol, a central-acting oral analgesic with combined opioid and noradrenergic properties, and Targinact, a combination of the opioid agonist oxycodone and the opioid antagonist naloxone have shown improvement in pain. Anticonvulsants such as gabapentin, pregabalin, lamotrigine, carbamazepine and tricyclic antidepressants (TCAs) can be trialed when attempting to manage chronic pain in PD. The selective serotonin and noradrenaline reuptake inhibitors (SNRIs) also possess pain relieving and antidepressant properties, but carry less of the risk of anticholinergic side effects seen in TCAs. Deep brain stimulation (DBS) of the subthalamic nucleus (STN) has been shown in multiple studies to be effective against various types of PD associated pain symptoms. Massage therapy (MT) is one of the most common forms of complementary and alternative medicine. Studies have shown that pressure applied during MT may stimulate vagal activity, promoting reduced anxiety and pain, as well as increasing levels of serotonin. In a survey study of PD patients, rehabilitative therapy and physical therapy were rated as the most effective for pain reduction, though with only temporary relief but these studies were uncontrolled. Yoga has been studied for patients with a wide array of neurological disorders. In summary, PD pathology is thought to have a modulating effect on pain sensation, which could amplify pain. This could help explain a portion of the higher incidence of chronic pain felt by PD patients. A treatment plan can be devised that may include dopaminergic agents, acetaminophen, NSAIDs, opioids, antidepressants, physical therapies, DBS and other options discussed in this review. A thorough assessment of patient history and physical examination should be made in patients with PD so chronic pain may be managed effectively.<\/jats:p>","DOI":"10.3390\/neurolint12030014","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T09:59:47Z","timestamp":1605693587000},"page":"61-76","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Chronic Pain Treatment Strategies in Parkinson\u2019s Disease"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7436-6206","authenticated-orcid":false,"given":"Amber","family":"Edinoff","sequence":"first","affiliation":[{"name":"Department of Psychiatry and Behavioral Medicine, Health Science Center, Louisiana State University Shreveport, Shreveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niro","family":"Sathivadivel","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Behavioral Medicine, Health Science Center, Louisiana State University Shreveport, Shreveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"McBride","sequence":"additional","affiliation":[{"name":"School of Medicine, Louisiana State University Shreveport, Shreveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson","family":"Parker","sequence":"additional","affiliation":[{"name":"School of Medicine, Louisiana State University Shreveport, Shreveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikezie","family":"Okeagu","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Louisiana State University New Orleans, New Orleans, LA 70112, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Louisiana State University New Orleans, New Orleans, LA 70112, USA"},{"name":"Department of Anesthesiology, Louisiana State University Shreveport, Shreveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, Stockton, CA 95211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica S.","family":"Kaye","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, Stockton, CA 95211, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Kaye","sequence":"additional","affiliation":[{"name":"School of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meeta","family":"M. Sheth","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Louisiana State University Shreveport, Shreveport, LA 71103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Louisiana State University Shreveport, Shreveport, LA 71103, USA"},{"name":"School of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA"},{"name":"College of Medicine-Phoenix, University of Arizona, Phoenix, AZ 85004, USA"},{"name":"Department of Anesthesiology, School of Medicine, Creighton University, Omaha, NE 68124, USA"},{"name":"Valley Anesthesiology and Pain Consultants\u2013Envision Physician Services, Phoenix, AZ 85004, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3652-6085","authenticated-orcid":false,"given":"Ivan","family":"Urits","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Louisiana State University Shreveport, Shreveport, LA 71103, USA"},{"name":"Southcoast Health, Southcoast Physicians Group Pain Medicine, Wareham, MA 02571, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,11,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.3233\/JPD-181474","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Parkinsons. Dis."},{"key":"ref_2","first-page":"504","article-title":"Parkinson\u2019s disease and its management part 1: Disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis","volume":"40","author":"DeMaagd","year":"2015","journal-title":"Pharmacol. Ther. T"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/mds.21667","article-title":"Quality of life in Parkinson\u2019s disease: The relative importance of the symptoms","volume":"23","author":"Shibley","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.clineuro.2016.06.014","article-title":"Impact of sleep quality on the quality of life of patients with Parkinson\u2019s disease: A questionnaire based study","volume":"148","author":"Pandey","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pain.2008.12.004","article-title":"Pain in Parkinson\u2019s disease: Prevalence and characteristics","volume":"141","author":"Beiske","year":"2009","journal-title":"Pain"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00415-017-8426-y","article-title":"Pain in Parkinson disease: A cross-sectional survey of its prevalence, specifics, and therapy","volume":"264","author":"Buhmann","year":"2017","journal-title":"J. Neurol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2147\/JMDH.S105857","article-title":"Pain management in patients with Parkinson\u2019s disease: Challenges and solutions","volume":"9","author":"Skogar","year":"2016","journal-title":"J. Multidiscip. Healthc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/mds.21813","article-title":"Nonmotor symptoms as presenting complaints in Parkinson\u2019s disease: A clinicopathological study","volume":"23","author":"Williams","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"a008862","DOI":"10.1101\/cshperspect.a008862","article-title":"The history of Parkinson\u2019s disease: Early clinical descriptions and neurological therapies","volume":"1","author":"Goetz","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/BMR-160720","article-title":"Chronic pain in Parkinson\u2019s disease: Frequency, characteristics, independent factors, and relationship with health-related quality of life","volume":"30","author":"Ozturk","year":"2017","journal-title":"J. Back Musculoskelet. Rehabil."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JPD-191683","article-title":"Parkinson\u2019s Disease in Women and Men: What\u2019s the Difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J. Parkinsons. Dis."},{"key":"ref_12","first-page":"749","article-title":"A systematic review of the worldwide prevalence and incidence of Parkinson\u2019s disease","volume":"94","author":"Muangpaisan","year":"2011","journal-title":"J. Med. Assoc. Thail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson\u2019s disease: Risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"Lancet Neurol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000445751","article-title":"The Incidence of Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"46","author":"Hirsch","year":"2016","journal-title":"Neuroepidemiology"},{"key":"ref_16","first-page":"595","article-title":"Parkinson\u2019s disease","volume":"48","author":"Worth","year":"2020","journal-title":"Medicine (UK)"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.amjmed.2019.03.001","article-title":"Parkinson\u2019s Disease and Parkinsonism","volume":"132","author":"Hayes","year":"2019","journal-title":"Am. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.lpm.2017.01.001","article-title":"\u00c9pid\u00e9miologie, facteurs de risque environnementaux et g\u00e9n\u00e9tiques de la maladie de Parkinson","volume":"46","author":"Delamarre","year":"2017","journal-title":"Press. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0037-1601567","article-title":"Genetic Forms of Parkinson\u2019s Disease","volume":"37","author":"Kim","year":"2017","journal-title":"Semin. Neurol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Ballard","year":"1983","journal-title":"Science (80)"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson\u2019s disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.12.008","article-title":"Environmental risk factors and Parkinson\u2019s disease: An umbrella review of meta-analyses","volume":"23","author":"Bellou","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fneur.2018.00156","article-title":"Diagnostic criteria for Parkinson\u2019s disease: From James Parkinson to the concept of prodromal disease","volume":"9","author":"Marsili","year":"2018","journal-title":"Front. Neurol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS research criteria for prodromal Parkinson\u2019s disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"411","DOI":"10.5604\/12321966.1232774","article-title":"Motor assessment in parkinson\u2019s disease","volume":"24","author":"Opara","year":"2017","journal-title":"Ann. Agric. Environ. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/practneurol-2014-000849","article-title":"Parkinson\u2019s disease: Chameleons and mimics","volume":"15","author":"Ali","year":"2015","journal-title":"Pract. Neurol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Mason","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00296-016-3481-8","article-title":"An overview of treatment approaches for chronic pain management","volume":"37","author":"Duarte","year":"2017","journal-title":"Rheumatol. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.emc.2004.12.005","article-title":"The Psychology of Pain","volume":"23","author":"Hansen","year":"2005","journal-title":"Emergy Med. Clin. N. Am."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.bja.2019.03.023","article-title":"Chronic pain: A review of its epidemiology and associated factors in population-based studies","volume":"123","author":"Mills","year":"2019","journal-title":"Br. J. Anaesth."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1080\/09593985.2016.1194651","article-title":"Clinical biopsychosocial physiotherapy assessment of patients with chronic pain: The first step in pain neuroscience education","volume":"32","author":"Wijma","year":"2016","journal-title":"Physiother. Theory Pract."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Derry, S., Wiffen, P.J., Kalso, E.A., Bell, R.F., Aldington, D., Phillips, T., Gaskell, H., and Moore, R.A. (2017). Topical analgesics for acute and chronic pain in adults\u2014an overview of Cochrane Reviews. Cochrane Database Syst. Rev., 12.","DOI":"10.1002\/14651858.CD008609.pub2"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","article-title":"Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults\u2014United States, 2016","volume":"67","author":"Dahlhamer","year":"2018","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/j.pain.0000000000000160","article-title":"A classification of chronic pain for ICD-11","volume":"156","author":"Treede","year":"2015","journal-title":"Pain"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/bja\/aet123","article-title":"Chronic pain epidemiology and its clinical relevance","volume":"111","author":"Torrance","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/archdischild-2013-304207","article-title":"Presentation and management of chronic pain","volume":"99","author":"Rajapakse","year":"2014","journal-title":"Arch. Dis. Child."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-015-0659-9","article-title":"Identification and Management of Chronic Pain in Primary Care: A Review","volume":"18","author":"Mills","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jocn.2017.08.002","article-title":"Impact of pain and pain subtypes on the quality of life of patients with Parkinson\u2019s disease","volume":"45","author":"Choi","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"ref_40","first-page":"63","article-title":"Pain in Parkinson\u2019s disease","volume":"5","author":"Ford","year":"1998","journal-title":"Clin. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00415-020-09723-5","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease","volume":"267","author":"Lubomski","year":"2020","journal-title":"J. Neurol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.14802\/jmd.18022","article-title":"Musculoskeletal Problems Affect the Quality of Life of Patients with Parkinson\u2019s Disease","volume":"11","author":"Kim","year":"2018","journal-title":"J. Mov. Disord."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/jnnp.52.1.63","article-title":"Frozen shoulder and other shoulder disturbances in Parkinson\u2019s disease","volume":"52","author":"Riley","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/mdc3.12386","article-title":"Postural, Bone, and Joint Disorders in Parkinson\u2019s Disease","volume":"3","author":"Rabin","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00586-018-5748-0","article-title":"The prevalence of chronic low back pain and lumbar deformities in patients with Parkinson\u2019s disease: Implications on spinal surgery","volume":"27","author":"Galazky","year":"2018","journal-title":"Eur. Spine J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/ageing\/afs161","article-title":"Parkinson\u2019s disease and osteoporosis","volume":"42","author":"Speelman","year":"2013","journal-title":"Age Ageing"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/bs.irn.2017.05.034","article-title":"Osteoporosis: A Hidden Nonmotor Face of Parkinson\u2019s Disease","volume":"Volume 134","author":"Metta","year":"2017","journal-title":"International Review of Neurobiology"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"vii7","DOI":"10.1007\/s00415-006-7003-6","article-title":"Dystonia in Parkinson\u2019s disease","volume":"253","author":"Tolosa","year":"2006","journal-title":"J. Neurol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2017.10.009","article-title":"Incobotulinum toxin A in Parkinson\u2019s disease with foot dystonia: A double blind randomized trial","volume":"46","author":"Rieu","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"104579","DOI":"10.1016\/j.nbd.2019.104579","article-title":"Dystonia and levodopa-induced dyskinesias in Parkinson\u2019s disease: Is there a connection?","volume":"132","author":"Calabresi","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1471-4159.2008.05417.x","article-title":"Striatal histone modifications in models of levodopa-induced dyskinesia","volume":"106","author":"Nicholas","year":"2008","journal-title":"J. Neurochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1523\/JNEUROSCI.0683-16.2016","article-title":"Dynamic DNA methylation regulates levodopa-induced Dyskinesia","volume":"36","author":"Figge","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"41156","DOI":"10.1038\/srep41156","article-title":"Faithful SGCE imprinting in iPSC-derived cortical neurons: An endogenous cellular model of myoclonus-dystonia","volume":"7","author":"Seibler","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_54","first-page":"2674","article-title":"Treatment with levodopa can affect latent vitamin B12 and folic acid deficiency. Patients with Parkinsonism run the risk of elevated homocysteine levels","volume":"100","year":"2003","journal-title":"Lakartidningen"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/mdc3.12688","article-title":"Levodopa-Induced Neuropathy: A Systematic Review","volume":"6","author":"Romagnolo","year":"2019","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/brain\/awv138","article-title":"Phosphorylated \u03b1-synuclein in skin nerve fibres differentiates Parkinson\u2019s disease from multiple system atrophy","volume":"138","author":"Zange","year":"2015","journal-title":"Brain"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jns.2018.06.022","article-title":"Peripheral neuropathic pain in idiopathic Parkinson\u2019s disease: Prevalence and impact on quality of life; a case controlled study","volume":"392","author":"Adewusi","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/mds.22716","article-title":"Pain in Parkinson\u2019s disease","volume":"25","author":"Ford","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/mds.23959","article-title":"Pain in Parkinson\u2019s disease","volume":"27","author":"Ha","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/mds.870110411","article-title":"Oral and genital pain syndromes in Parkinson\u2019s disease","volume":"11","author":"Ford","year":"1996","journal-title":"Mov. Disord."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.parkreldis.2019.04.025","article-title":"How to diagnose parkinsonian central pain?","volume":"64","author":"Marques","year":"2019","journal-title":"Park. Relat. Disord."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1212\/01.wnl.0000295669.12443.d3","article-title":"Neurophysiologic study of central pain in patients with Parkinson disease","volume":"69","author":"Schestatsky","year":"2007","journal-title":"Neurology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2017.10.010","article-title":"Chronic pain and pain processing in Parkinson\u2019s disease","volume":"87","author":"Blanchet","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Florin, E., Koschmieder, K.C., Schnitzler, A., and Becker, S. (2020). Recovery of Impaired Endogenous Pain Modulation by Dopaminergic Medication in Parkinson\u2019s Disease. Mov. Disord.","DOI":"10.1002\/mds.28241"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1097\/j.pain.0000000000000494","article-title":"Mesolimbic dopamine signaling in acute and chronic pain: Implications for motivation, analgesia, and addiction","volume":"157","author":"Taylor","year":"2016","journal-title":"Pain"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(98)00184-5","article-title":"The cortical representation of pain","volume":"79","author":"Treede","year":"1999","journal-title":"Pain"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1097\/j.pain.0000000000000923","article-title":"Altered neural responses to heat pain in drug-naive patients with Parkinson disease","volume":"158","author":"Forkmann","year":"2017","journal-title":"Pain"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.neubiorev.2005.03.001","article-title":"Pain in Parkinson\u2019s disease and multiple sclerosis: Its relation to the medial and lateral pain systems","volume":"29","author":"Scherder","year":"2005","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.parkreldis.2013.02.003","article-title":"Nociceptive brain activation in patients with neuropathic pain related to Parkinson\u2019s disease","volume":"19","author":"Thalamas","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.tins.2015.09.003","article-title":"Brain Circuits Encoding Reward from Pain Relief","volume":"38","author":"Navratilova","year":"2015","journal-title":"Trends Neurosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/7854_2014_330","article-title":"Preclinical assessment of pain: Improving models in discovery research","volume":"20","author":"King","year":"2014","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3988\/jcn.2019.15.3.321","article-title":"Restless legs syndrome in parkinson\u2019s disease patients: Clinical features including motor and nonmotor symptoms","volume":"15","author":"You","year":"2019","journal-title":"J. Clin. Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archneur.59.3.421","article-title":"Exploring the relationship between Parkinson disease and restless legs syndrome","volume":"59","author":"Ondo","year":"2002","journal-title":"Arch. Neurol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.sleep.2014.03.025","article-title":"Restless legs syndrome\/Willis-Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria-history, rationale, description, and significance","volume":"15","author":"Allen","year":"2014","journal-title":"Sleep Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2009.08.020","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s Disease","volume":"289","author":"Jost","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/mds.20942","article-title":"Excess burden of constipation in Parkinson\u2019s disease: A pilot study","volume":"21","author":"Kaye","year":"2006","journal-title":"Mov. Disord."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s10286-005-0253-z","article-title":"Symptoms of autonomic failure in Parkinson\u2019s disease: Prevalence and impact on daily life","volume":"15","author":"Magerkurth","year":"2005","journal-title":"Clin. Auton. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","article-title":"Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology","volume":"112","author":"Manfredsson","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mds.25298","article-title":"Enteric alpha-synuclein expression is increased in Parkinson\u2019s disease but not Alzheimer\u2019s disease","volume":"28","author":"Gold","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/mds.22051","article-title":"Neural control of the gastrointestinal tract: Implications for Parkinson disease","volume":"23","author":"Cersosimo","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/mds.25522","article-title":"The role of small intestinal bacterial overgrowth in Parkinson\u2019s disease","volume":"28","author":"Fasano","year":"2013","journal-title":"Mov. Disord."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1468-1331.2011.03643.x","article-title":"Treatment for Helicobacter pylori infection and risk of parkinson\u2019s disease in Denmark","volume":"19","author":"Nielsen","year":"2012","journal-title":"Eur. J. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/jcph.678","article-title":"A Randomized Controlled Exploratory Pilot Study to Evaluate the Effect of Rotigotine Transdermal Patch on Parkinson\u2019s Disease-Associated Chronic Pain","volume":"56","author":"Rascol","year":"2016","journal-title":"J. Clin. Pharmacol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/WCO.0000000000000711","article-title":"Pain in Parkinson\u02bcs disease","volume":"32","author":"Rukavina","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrneurol.2012.54","article-title":"Pains in Parkinson disease-many syndromes under one umbrella","volume":"8","author":"Wasner","year":"2012","journal-title":"Nat. Rev. Neurol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11910-016-0628-7","article-title":"Integrated Approach for Pain Management in Parkinson Disease","volume":"16","author":"Geroin","year":"2016","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1517\/14728214.2012.677949","article-title":"Emerging analgesic drugs for Parkinson\u2019s disease","volume":"17","author":"Rey","year":"2012","journal-title":"Expert Opin. Emergy Drugs"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jns.2009.08.018","article-title":"The pathophysiological basis of sensory disturbances in Parkinson\u2019s disease","volume":"289","author":"Juri","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/mds.22596","article-title":"Intrajejunal levodopa infusion in Parkinson\u2019s disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life","volume":"24","author":"Honig","year":"2009","journal-title":"Mov. Disord."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10194-008-0003-4","article-title":"Burning mouth syndrome responsive to pramipexol","volume":"9","author":"Rodrigues","year":"2008","journal-title":"J. Headache Pain"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/art.21191","article-title":"A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications","volume":"52","author":"Holman","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/jnnp.53.2.96","article-title":"Subcutaneous apomorphine in the treatment of Parkinson\u2019s disease","volume":"53","author":"Frankel","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1531-8257(200001)15:1<167::AID-MDS1029>3.0.CO;2-8","article-title":"Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson\u2019s disease","volume":"15","author":"Factor","year":"2000","journal-title":"Mov. Disord."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.3233\/JPD-202069","article-title":"Management of Pain in Parkinson\u2019s Disease","volume":"10","author":"Buhmann","year":"2020","journal-title":"J. Parkinsons. Dis."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JPD-160911","article-title":"Effects of Safinamide on Pain in Fluctuating Parkinson\u2019s Disease Patients: A Post-Hoc Analysis","volume":"7","author":"Cattaneo","year":"2017","journal-title":"J. Parkinsons. Dis."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S1474-4422(15)00243-4","article-title":"Prolonged-release oxycodone-naloxone for treatment of severe pain in patients with Parkinson\u2019s disease (PANDA): A double-blind, randomised, placebo-controlled trial","volume":"14","author":"Trenkwalder","year":"2015","journal-title":"Lancet Neurol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.2147\/JPR.S164939","article-title":"Effects of tapentadol on pain, motor symptoms and cognitive functions in Parkinson\u2019s disease","volume":"11","author":"Freo","year":"2018","journal-title":"J. Pain Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/wnf.0b013e3180340319","article-title":"The effect of duloxetine on primary pain symptoms in Parkinson disease","volume":"30","author":"Djaldetti","year":"2007","journal-title":"Clin. Neuropharmacol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/mds.21694","article-title":"Botulinum toxin treatment of lateral axial dystonia in Parkinsonism","volume":"22","author":"Bonanni","year":"2007","journal-title":"Mov. Disord."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/cjn.2016.279","article-title":"Botulinum Toxin Use in Refractory Pain and Other Symptoms in Parkinsonism","volume":"43","author":"Bruno","year":"2016","journal-title":"Can. J. Neurol. Sci."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.parkreldis.2014.07.015","article-title":"Botulinum toxin type A potentiates the effect of neuromotor rehabilitation of Pisa syndrome in Parkinson disease: A placebo controlled study","volume":"20","author":"Tassorelli","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/mds.1186","article-title":"Treatment of dystonic clenched fist with botulinum toxin","volume":"16","author":"Cordivari","year":"2001","journal-title":"Mov. Disord."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3344\/kjp.2011.24.1.1","article-title":"Application of botulinum toxin in pain management","volume":"24","author":"Sim","year":"2011","journal-title":"Korean J. Pain"},{"key":"ref_104","unstructured":"(2020, September 20). The Use of Botox in Advanced Parkinson\u2019s Patients Experiencing Pain, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02472210."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00415-009-0908-0","article-title":"Chronic subthalamic deep brain stimulation improves pain in Parkinson disease","volume":"255","author":"Kim","year":"2008","journal-title":"J. Neurol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1212\/WNL.0b013e3182a08d00","article-title":"Central pain modulation after subthalamic nucleus stimulation: A crossover randomized trial","volume":"81","author":"Marques","year":"2013","journal-title":"Neurology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.pain.2012.07.026","article-title":"Effect of subthalamic deep brain stimulation on pain in Parkinson\u2019s disease","volume":"153","author":"Dellapina","year":"2012","journal-title":"Pain"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.parkreldis.2014.03.011","article-title":"Deep brain stimulation of the subthalamic nucleus improves pain in Parkinson\u2019s disease","volume":"20","author":"Pellaprat","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3171\/2011.7.JNS11158","article-title":"Subthalamic nucleus stimulation for attenuation of pain related to Parkinson disease: Clinical article","volume":"116","author":"Oshima","year":"2012","journal-title":"J. Neurosurg."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1001\/jamaneurol.2015.8","article-title":"An 8-year follow-up on the effect of subthalamic nucleus deep brain stimulation on pain in Parkinson disease","volume":"72","author":"Jung","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1227\/NEU.0b013e3182266664","article-title":"The benefit of subthalamic deep brain stimulation for pain in parkinson disease: A 2-year follow-up study","volume":"70","author":"Kim","year":"2012","journal-title":"Neurosurgery"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3171\/jns.1999.91.2.0198","article-title":"Unilateral pallidotomy for reduction of parkinsonian pain","volume":"91","author":"Honey","year":"1999","journal-title":"J. Neurosurg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3171\/jns.1992.76.1.0053","article-title":"Leksell\u2019s posteroventral pallidotomy in the treatment of Parkinson\u2019s disease","volume":"76","author":"Laitinen","year":"1992","journal-title":"J. Neurosurg."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jns.2011.06.021","article-title":"Effect of deep brain stimulation on pain in Parkinson disease","volume":"310","author":"Kim","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"102340","DOI":"10.1016\/j.ctim.2020.102340","article-title":"Massage therapy as a complementary treatment for Parkinson\u2019s disease: A Systematic Literature Review","volume":"49","author":"Angelopoulou","year":"2020","journal-title":"Complement. Ther. Med."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/mds.10134","article-title":"Acupuncture therapy for the symptoms of Parkinson\u2019s disease","volume":"17","author":"Shulman","year":"2002","journal-title":"Mov. Disord."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/mds.20763","article-title":"Impact of an exercise program on physical, emotional, and social aspects of quality of life of individuals with Parkinson\u2019s disease","volume":"21","author":"Cardoso","year":"2006","journal-title":"Mov. Disord."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"232473","DOI":"10.4061\/2011\/232473","article-title":"Effects of a flexibility and relaxation programme, walking, and nordic walking on parkinson\u2019s disease","volume":"2011","author":"Reuter","year":"2011","journal-title":"J. Aging Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jocn.2017.05.012","article-title":"Evidence based effects of yoga in neurological disorders","volume":"43","author":"Mooventhan","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.17761\/2020-D-18-00028","article-title":"Yoga Improves Balance and Low-Back Pain, but Not Anxiety, in People with Parkinson\u2019s Disease","volume":"30","author":"Myers","year":"2019","journal-title":"Int. J. Yoga Therap."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/WNF.0000000000000016","article-title":"Cannabis (Medical Marijuana) treatment for motor and non-motor symptoms of parkinson disease: An open-label observational study","volume":"37","author":"Lotan","year":"2014","journal-title":"Clin. Neuropharmacol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/ejp.942","article-title":"Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson\u2019s disease","volume":"21","author":"Shohet","year":"2017","journal-title":"Eur. J. Pain (UK)"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10654-014-9921-4","article-title":"Dairy foods intake and risk of Parkinson\u2019s disease: A dose-response meta-analysis of prospective cohort studies","volume":"29","author":"Jiang","year":"2014","journal-title":"Eur. J. Epidemiol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/aje\/kwk089","article-title":"Consumption of dairy products and risk of parkinson\u2019s disease","volume":"165","author":"Chen","year":"2007","journal-title":"Am. J. Epidemiol."}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2035-8377\/12\/3\/14\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:33:56Z","timestamp":1760178836000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/12\/3\/14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,18]]},"references-count":124,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["neurolint12030014"],"URL":"https:\/\/doi.org\/10.3390\/neurolint12030014","relation":{},"ISSN":["2035-8377"],"issn-type":[{"value":"2035-8377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,18]]}}}